Goiter clinical trials

The registry lists 66 studies for Goiter across more than 10 countries. 11 are recruiting or about to start. 37 of them are mainly about Goiter (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-03. Counting its 3 narrower conditions too, such as Graves Ophthalmopathy: 398 studies, 117 open.

Get an email when these change. Save the Goiter studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 37
Status unknown: 15
Recruiting: 6
Not yet recruiting: 3
Enrolling by invitation: 2
Active, not recruiting: 1

Phase

Phase 4: 6
Phase 2: 3
Phase 1: 2
Phase 3: 1

Where

United States: 7
Denmark: 7
Poland: 5
Egypt: 5
Italy: 4
Canada: 4

Who runs them

Jagiellonian University (5) · Assiut University (4) · Aristotle University Of Thessaloniki (3) · University of Southern Denmark (2) · Umraniye Education and Research Hospital (2) · Centre de recherche du Centre hospitalier universitaire de Sherbrooke (1) · Sarasota Memorial Health Care System (1) · ProMedica Health System (1)

What is being tested here

Drugs under test in Goiter studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Dexmedetomidine	0	0	1
Bupivacaine	0	0	1
Hyaluronic Acid	0	0	1
Triiodothyronine	0	0	1
Ketorolac	0	0	1
Acetaminophen	0	0	1
Tramadol	0	0	1
Indocyanine Green	0	0	1
Fibrinogen	0	0	1
Thrombin	0	0	1

Coming up

0phase 3 studies under way

7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Nov 2026Thyroid Artery Goitre Embolization Trial A Pilot Study Investigating Thyroid Artery Embolisation as a Treatment for Large Thyroid Nodules · Royal Berkshire NHS Foundation Trust
Nov 2026Dysphagia After Thyroidectomy · Istituto Auxologico Italiano
Feb 2027The Association Between Bilateral Intermediate Cervical Plexus Block During Total Thyroidectomy and Surgical Stress Response · University Hospital Dubrava
Mar 2027ThyMoves: Screening and Exercise to Improve Muscle, Enhance Quality of Life, and Reduce Fall Risk in Thyroid Disease · Aalborg University Hospital
Apr 2027Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry · Sarasota Memorial Health Care System
Apr 2027Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System · Pulse Biosciences, Inc.
Oct 2027Role of Total Thyroidectomy in Relieving Local Symptoms in Hashimoto's Thyroiditis · Assiut University

Who these studies take

Of the 6 Goiter studies recruiting now, 5 (83%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (17%) take healthy volunteers.

Recruiting studies that take each age, of 6
Age	Women	Men
10	0 (0%)	0 (0%)
18	6 (100%)	6 (100%)
30	6 (100%)	6 (100%)
40	6 (100%)	6 (100%)
50	6 (100%)	6 (100%)
65	6 (100%)	6 (100%)
75	6 (100%)	6 (100%)
85	6 (100%)	6 (100%)

Across all 66 studies, recruiting or not: 30% stop at 75 or younger and 18% at 65; 15% take children; 5% are for women only and 0% for men only; 17% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered1

Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye DiseaseOct 21, 2026NCT07885605

Studies

Recruiting first, then most recently updated. Showing 50 of 66. Browse all 66 → or search them.